APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxyprogesterone Caproate Injection

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Selected research

Industry Growth & Trends

Global Hydroxyprogesterone Caproate Injection Industry Growth and Trends Forecast to 2032

30 December 202591 pages

Choose your research edition.

Industry ResearchHydroxyprogesterone Caproate Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxyprogesterone Caproate Injection Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Hydroxyprogesterone Caproate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxyprogesterone Caproate Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxyprogesterone Caproate Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Hydroxyprogesterone Caproate Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hydroxyprogesterone Caproate Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hydroxyprogesterone Caproate Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hydroxyprogesterone Caproate Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hydroxyprogesterone Caproate Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hydroxyprogesterone Caproate Injection Market by Company

AMAG Pharmaceuticals

Mcguff Pharmaceuticals Inc

Aspen Oss B.V

American Regent, Inc.

Mylan Institutional

Hydroxyprogesterone Caproate Injection Segment by Type

1 mL Injection(Including 1.1 mL)

5 mL Injection

Hydroxyprogesterone Caproate Injection Segment by Application

Hospitals Injection

Clinics Injection

Hydroxyprogesterone Caproate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyprogesterone Caproate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxyprogesterone Caproate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyprogesterone Caproate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxyprogesterone Caproate Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hydroxyprogesterone Caproate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1 mL Injection(Including 1.1 mL) Table 2. Major Company of 5 mL Injection Table 3. Global Hydroxyprogesterone Caproate Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Hydroxyprogesterone Caproate Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Hydroxyprogesterone Caproate Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Hydroxyprogesterone Caproate Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Hydroxyprogesterone Caproate Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Hydroxyprogesterone Caproate Injection Industry Trends Table 25. Hydroxyprogesterone Caproate Injection Industry Drivers Table 26. Hydroxyprogesterone Caproate Injection Industry Opportunities and Challenges Table 27. Hydroxyprogesterone Caproate Injection Industry Restraints Table 28. Global Hydroxyprogesterone Caproate Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Company (2021-2026) Table 30. Global Hydroxyprogesterone Caproate Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Hydroxyprogesterone Caproate Injection Sales Share by Company (2021-2026) Table 32. Global Hydroxyprogesterone Caproate Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Hydroxyprogesterone Caproate Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Hydroxyprogesterone Caproate Injection Major Company Production Sites and Headquarters Table 35. Global Hydroxyprogesterone Caproate Injection Company, Product Type & Application Table 36. Global Hydroxyprogesterone Caproate Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Hydroxyprogesterone Caproate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Hydroxyprogesterone Caproate Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Hydroxyprogesterone Caproate Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Hydroxyprogesterone Caproate Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Hydroxyprogesterone Caproate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Hydroxyprogesterone Caproate Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Hydroxyprogesterone Caproate Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Hydroxyprogesterone Caproate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Hydroxyprogesterone Caproate Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Hydroxyprogesterone Caproate Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Hydroxyprogesterone Caproate Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Hydroxyprogesterone Caproate Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Hydroxyprogesterone Caproate Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (US$ Million) Table 71. AMAG Pharmaceuticals Company Information Table 72. AMAG Pharmaceuticals Business Overview Table 73. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio Table 75. AMAG Pharmaceuticals Recent Development Table 76. Mcguff Pharmaceuticals Inc Company Information Table 77. Mcguff Pharmaceuticals Inc Business Overview Table 78. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio Table 80. Mcguff Pharmaceuticals Inc Recent Development Table 81. Aspen Oss B.V Company Information Table 82. Aspen Oss B.V Business Overview Table 83. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio Table 85. Aspen Oss B.V Recent Development Table 86. American Regent, Inc. Company Information Table 87. American Regent, Inc. Business Overview Table 88. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio Table 90. American Regent, Inc. Recent Development Table 91. Mylan Institutional Company Information Table 92. Mylan Institutional Business Overview Table 93. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio Table 95. Mylan Institutional Recent Development Table 96. North America Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 98. North America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021-2026) Table 99. North America Hydroxyprogesterone Caproate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Country (2027-2032) Table 101. North America Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Hydroxyprogesterone Caproate Injection Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Hydroxyprogesterone Caproate Injection Market Share by Country (2021-2026) Table 104. North America Hydroxyprogesterone Caproate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Hydroxyprogesterone Caproate Injection Market Share Forecast by Country (2027-2032) Table 106. Europe Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 108. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021-2026) Table 109. Europe Hydroxyprogesterone Caproate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Hydroxyprogesterone Caproate Injection Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Hydroxyprogesterone Caproate Injection Market Share by Country (2021-2026) Table 114. Europe Hydroxyprogesterone Caproate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Hydroxyprogesterone Caproate Injection Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Hydroxyprogesterone Caproate Injection Market Share by Country (2021-2026) Table 124. Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Hydroxyprogesterone Caproate Injection Market Share Forecast by Country (2027-2032) Table 126. Latin America Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 128. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021-2026) Table 129. Latin America Hydroxyprogesterone Caproate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Hydroxyprogesterone Caproate Injection Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Hydroxyprogesterone Caproate Injection Market Share by Country (2021-2026) Table 134. Latin America Hydroxyprogesterone Caproate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Hydroxyprogesterone Caproate Injection Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Hydroxyprogesterone Caproate Injection Market Share by Country (2021-2026) Table 144. Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Hydroxyprogesterone Caproate Injection Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Hydroxyprogesterone Caproate Injection Distributors List Table 149. Hydroxyprogesterone Caproate Injection Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Hydroxyprogesterone Caproate Injection Image Figure 2. Global Hydroxyprogesterone Caproate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxyprogesterone Caproate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxyprogesterone Caproate Injection Sales (2021-2032) & (K Units) Figure 5. 1 mL Injection(Including 1.1 mL) Image Figure 6. Global 1 mL Injection(Including 1.1 mL) Sales YoY Growth (2021-2032) & (K Units) Figure 7. 5 mL Injection Image Figure 8. Global 5 mL Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Hydroxyprogesterone Caproate Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Hydroxyprogesterone Caproate Injection Market Share by Type 2025 VS 2032 Figure 11. North America Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Hydroxyprogesterone Caproate Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Injection Image Figure 24. Global Hospitals Injection Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinics Injection Image Figure 26. Global Clinics Injection Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Hydroxyprogesterone Caproate Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Hydroxyprogesterone Caproate Injection Market Share by Application 2025 VS 2032 Figure 29. North America Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Hydroxyprogesterone Caproate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Hydroxyprogesterone Caproate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Hydroxyprogesterone Caproate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Hydroxyprogesterone Caproate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Hydroxyprogesterone Caproate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Hydroxyprogesterone Caproate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hydroxyprogesterone Caproate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Hydroxyprogesterone Caproate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Hydroxyprogesterone Caproate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Hydroxyprogesterone Caproate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Hydroxyprogesterone Caproate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hydroxyprogesterone Caproate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Hydroxyprogesterone Caproate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Hydroxyprogesterone Caproate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Hydroxyprogesterone Caproate Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Hydroxyprogesterone Caproate Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 1 mL Injection(Including 1.1 mL)
  • 5 mL Injection
Applications
  • Hospitals Injection
  • Clinics Injection
Companies covered
  • AMAG Pharmaceuticals
  • Mcguff Pharmaceuticals Inc
  • Aspen Oss B.V
  • American Regent, Inc.
  • Mylan Institutional

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hydroxyprogesterone Caproate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hydroxyprogesterone Caproate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hydroxyprogesterone Caproate Injection Market by Type
  6. 1.3.1 1 mL Injection(Including 1.1 mL)
  7. 1.3.2 5 mL Injection
  8. 1.4 Global Hydroxyprogesterone Caproate Injection Market Size by Type
  9. 1.4.1 Global Hydroxyprogesterone Caproate Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Hydroxyprogesterone Caproate Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Hydroxyprogesterone Caproate Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Hydroxyprogesterone Caproate Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Hydroxyprogesterone Caproate Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Hydroxyprogesterone Caproate Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hydroxyprogesterone Caproate Injection Industry Trends
  2. 2.2 Hydroxyprogesterone Caproate Injection Industry Drivers
  3. 2.3 Hydroxyprogesterone Caproate Injection Industry Opportunities and Challenges
  4. 2.4 Hydroxyprogesterone Caproate Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hydroxyprogesterone Caproate Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Hydroxyprogesterone Caproate Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Hydroxyprogesterone Caproate Injection Price (2021-2026)
  4. 3.4 Global Hydroxyprogesterone Caproate Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxyprogesterone Caproate Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Hydroxyprogesterone Caproate Injection Company, Product Type & Application
  7. 3.7 Global Hydroxyprogesterone Caproate Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxyprogesterone Caproate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxyprogesterone Caproate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxyprogesterone Caproate Injection Tier 1, Tier 2, and Tier 3
4 Hydroxyprogesterone Caproate Injection Regional Status and Outlook
  1. 4.1 Global Hydroxyprogesterone Caproate Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hydroxyprogesterone Caproate Injection Historic Market Size by Region
  3. 4.2.1 Global Hydroxyprogesterone Caproate Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hydroxyprogesterone Caproate Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hydroxyprogesterone Caproate Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hydroxyprogesterone Caproate Injection Forecasted Market Size by Region
  7. 4.3.1 Global Hydroxyprogesterone Caproate Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hydroxyprogesterone Caproate Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hydroxyprogesterone Caproate Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hydroxyprogesterone Caproate Injection by Application
  1. 5.1 Hydroxyprogesterone Caproate Injection Market by Application
  2. 5.1.1 Hospitals Injection
  3. 5.1.2 Clinics Injection
  4. 5.2 Global Hydroxyprogesterone Caproate Injection Market Size by Application
  5. 5.2.1 Global Hydroxyprogesterone Caproate Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Hydroxyprogesterone Caproate Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Hydroxyprogesterone Caproate Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Hydroxyprogesterone Caproate Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Hydroxyprogesterone Caproate Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Hydroxyprogesterone Caproate Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AMAG Pharmaceuticals
  2. 6.1.1 AMAG Pharmaceuticals Company Information
  3. 6.1.2 AMAG Pharmaceuticals Business Overview
  4. 6.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio
  6. 6.1.5 AMAG Pharmaceuticals Recent Developments
  7. 6.2 Mcguff Pharmaceuticals Inc
  8. 6.2.1 Mcguff Pharmaceuticals Inc Company Information
  9. 6.2.2 Mcguff Pharmaceuticals Inc Business Overview
  10. 6.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio
  12. 6.2.5 Mcguff Pharmaceuticals Inc Recent Developments
  13. 6.3 Aspen Oss B.V
  14. 6.3.1 Aspen Oss B.V Company Information
  15. 6.3.2 Aspen Oss B.V Business Overview
  16. 6.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio
  18. 6.3.5 Aspen Oss B.V Recent Developments
  19. 6.4 American Regent, Inc.
  20. 6.4.1 American Regent, Inc. Company Information
  21. 6.4.2 American Regent, Inc. Business Overview
  22. 6.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio
  24. 6.4.5 American Regent, Inc. Recent Developments
  25. 6.5 Mylan Institutional
  26. 6.5.1 Mylan Institutional Company Information
  27. 6.5.2 Mylan Institutional Business Overview
  28. 6.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio
  30. 6.5.5 Mylan Institutional Recent Developments
7 North America by Country
  1. 7.1 North America Hydroxyprogesterone Caproate Injection Sales by Country
  2. 7.1.1 North America Hydroxyprogesterone Caproate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Hydroxyprogesterone Caproate Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hydroxyprogesterone Caproate Injection Market Size by Country
  6. 7.2.1 North America Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hydroxyprogesterone Caproate Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Hydroxyprogesterone Caproate Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hydroxyprogesterone Caproate Injection Sales by Country
  2. 8.1.1 Europe Hydroxyprogesterone Caproate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Hydroxyprogesterone Caproate Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hydroxyprogesterone Caproate Injection Market Size by Country
  6. 8.2.1 Europe Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hydroxyprogesterone Caproate Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hydroxyprogesterone Caproate Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Country
  2. 9.1.1 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hydroxyprogesterone Caproate Injection Sales by Country
  2. 10.1.1 South America Hydroxyprogesterone Caproate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Hydroxyprogesterone Caproate Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hydroxyprogesterone Caproate Injection Market Size by Country
  6. 10.2.1 South America Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hydroxyprogesterone Caproate Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Hydroxyprogesterone Caproate Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country
  2. 11.1.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hydroxyprogesterone Caproate Injection Value Chain Analysis
  2. 12.1.1 Hydroxyprogesterone Caproate Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hydroxyprogesterone Caproate Injection Production Mode & Process
  7. 12.2 Hydroxyprogesterone Caproate Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hydroxyprogesterone Caproate Injection Distributors
  10. 12.2.3 Hydroxyprogesterone Caproate Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst